Filing Details

Accession Number:
0001209191-20-037674
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-18 17:16:26
Reporting Period:
2020-06-17
Accepted Time:
2020-06-18 17:16:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189140 R John Stuelpnagel C/O 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2020-06-17 3,795 $88.63 582,196 No 4 S Direct
Class A Common Stock Disposition 2020-06-17 2,648 $89.48 579,548 No 4 S Direct
Class A Common Stock Disposition 2020-06-17 1,057 $90.13 578,491 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
  2. This transaction was executed in multiple trades at prices ranging from $87.99 to $88.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  3. This transaction was executed in multiple trades at prices ranging from $88.99 to $89.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  4. This transaction was executed in multiple trades at prices ranging from $89.99 to $90.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.